The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index, and 1 are not checked yet.
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Open accessAbstract
Monamines subserve many critical roles in the brain, and monoaminergic drugs such as amphetamine have a long history in the treatment of neuropsychiatric disorders and also as a substance of abuse. The clinical effects of amphetamine are quite variable, from positive effects on mood and cognition in some individuals, to negative responses in others, perhaps related to individual variations in monaminergic function and monoamine system genes. We explored the effect of a functional polymorphism ( val 158 -met ) in the catechol O -methyltransferase gene, which has been shown to modulate prefrontal dopamine in animals and prefrontal cortical function in humans, on the modulatory actions of amphetamine on the prefrontal cortex. Amphetamine enhanced the efficiency of prefrontal cortex function assayed with functional MRI during a working memory task in subjects with the high enzyme activity val / val genotype, who presumably have relatively less prefrontal synaptic dopamine, at all levels of task difficulty. In contrast, in subjects with the low activity met / met genotype who tend to have superior baseline prefrontal function, the drug had no effect on cortical efficiency at low-to-moderate working memory load and caused deterioration at high working memory load. These data illustrate an application of functional neuroimaging in pharmacogenomics and extend basic evidence of an inverted-“U” functional-response curve to increasing dopamine signaling in the prefrontal cortex. Further, individuals with the met / met catechol O -methyltransferase genotype appear to be at increased risk for an adverse response to amphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that WM performance in psychotic and healthy subjects rely on dopamine levels within the PFC (Dumontheil et al., 2011; Mattay et al., 2003; Okubo et al., 1997).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some human participants who had lower baseline dopamine levels (due to Val/Val allele in COMT gene), showed improved WM performance after dexamphetamine administration, while others who had a higher dopamine level (met/met allele subjects) showed the opposite effect”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, methionine substitutions in COMT increase the stress response in mice75 and make humans more susceptible to cognitive impairment following stress and psychostimulant medication74.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the methionine substitution in the COMT protein that results from one of the COMT polymorphisms reduces the ability of COMT to catabolize dopamine and increases vulnerability to stress- or stimulant-induced working memory impairments in human subjects74 and in mice75.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citationModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
Livak, K. (1999) · Genetic Analysis, Techniques and Applications (GATA) · doi:10.1016/s1050-3862(98)00019-9 · Cited by 1,352
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Allelic discrimination using fluorogenic probes and the 5' nuclease assay
Foitzi, T. (1999) · Medical Entomology and Zoology · Cited by 783
Callicott, J. H. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.1.20 · Cited by 771
Self-citation
Research works printed but not linked: 1
- P Mannisto, S Kaakkola Pharmacol Rev 51, 593–628 (1999).
Cited by
Sorted by citations
Items 301–400 of 893
Tunbridge, E. M., & Harrison, P. J. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_97 · Cited by 61
COMT but not serotonin‐related genes modulates the influence of childhood abuse on anger traits
Perroud, N. A., Jaussent, I., Guillaume, S., Bellivier, F., Baud, P., Jollant, F., Leboyer, M., Lewis, C. M., Malafosse, A., & Courtet, P. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00547.x · Cited by 64
Domschke, K., Gajewska, A., Winter, B., Herrmann, M. J., Warrings, B., Mühlberger, A., Wosnitza, K., Glotzbach, E., Conzelmann, A., Dlugos, A. M., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.253 · Cited by 64
Comer, S. D., Bickel, W. K., Yi, R., de Wit, H., Higgins, S. T., Wenger, G. R., Johanson, C., & Kreek, M. J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833bb9f8 · Cited by 60
Striatal Dopamine Influences the Default Mode Network to Affect Shifting between Object Features
Dang, L. C., Donde, A., Madison, C. M., O’Neil, J. P., & Jagust, W. J. (2012) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00252 · Cited by 61
Lapish, C. C., Ahn, S., Evangelista, L., So, K., Seamans, J. K., & Phillips, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1342-1 · Cited by 60
Sambataro, F., Reed, J. D., Murty, V. P., Das, S., Tan, H. Y., Callicott, J. H., Weinberger, D. R., & Mattay, V. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.014 · Cited by 63
Self-citationNeuroimaging and Psychophysiological Measurement in Organizational Research
Lee, N. J., & Chamberlain, L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1412.003 · Cited by 64
Effects of dopamine‐related gene–gene interactions on working memory component processes
Stelzel, C., Basten, U., Montag, C., Reuter, M., & Fiebach, C. J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06647.x · Cited by 61
Lelli-Chiesa, G., Kempton, M. J., Jogia, J., Tatarelli, R., Girardi, P., Powell, J. F., Collier, D. A., & Frangou, S. (2010) · Psychological Medicine · doi:10.1017/s0033291710001431 · Cited by 59
Miskowiak, K. W., Kjærstad, H. L., Støttrup, M. M., Svendsen, A., Demant, K. M., Hoeffding, L., Tm, W., Burdick, K. E., Domschke, K., Carvalho, A., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12497 · Cited by 60
Taerk, E., Grizenko, N., Amor, L. B., Lageix, P., Mbékou, V., Deguzman, R., Torkamanzehi, A., Ter-Stepanian, M., Baron, C., & Joober, R. (2004) · BMC Medical Genetics · doi:10.1186/1471-2350-5-30 · Cited by 60
Haberstick, B. C., & Smolen, A. (2004) · Behavior Genetics · doi:10.1023/b:bege.0000038492.50446.25 · Cited by 59
Lyon, L., Burnet, P. W. J., Kew, J. N. C., Corti, C., Rawlins, J. N. P., Lane, T. A., Filippis, B. D., Harrison, P. J., & Bannerman, D. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.145 · Cited by 58
The Ultimate Intra-/Extra-Dimensional Attentional Set-Shifting Task for Mice
Scheggia, D., Bebensee, A., Weinberger, D. R., & Papaleo, F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.021 · Cited by 61
Self-citationSchlagenhauf, F., Wüstenberg, T., Schmack, K., Dinges, M., Wrase, J., Koslowski, M., Kienast, T., Bauer, M., Gallinat, J., Juckel, G., et al. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.013 · Cited by 57
Wu, K., O’Keeffe, D., Politis, M., O’Keeffe, G. C., Robbins, T. W., Bose, S. K., Brooks, D. J., Piccini, P. P., & Barker, R. A. (2012) · Brain · doi:10.1093/brain/aws157 · Cited by 59
Sex Differences in COMT Polymorphism Effects on Prefrontal Inhibitory Control in Adolescence
White, T. P., Loth, E., Rubia, K., Krabbendam, L., Whelan, R., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.107 · Cited by 59
Honey, G. D., & Fletcher, P. C. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.036 · Cited by 59
Fischer, H., Nyberg, L., Karlsson, S., Karlsson, P., Brehmer, Y., Rieckmann, A., MacDonald, S. W. S., Farde, L., & Bäckman, L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.013 · Cited by 68
Genetic Influences on Neural Plasticity
Pearson‐Fuhrhop, K. M., & Cramer, S. C. (2010) · PM&R · doi:10.1016/j.pmrj.2010.09.011 · Cited by 59
Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder
Maoz, H., Tsviban, L., Gvirts, H. Z., Shamay‐Tsoory, S., Levkovitz, Y., Watemberg, N. M., & Bloch, Y. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113492030 · Cited by 60
Preclinical research into cognition enhancers
Sarter, M. F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.004 · Cited by 59
Stelzel, C., Fiebach, C. J., Cools, R., Tafazoli, S., & D’Esposito, M. (2013) · Cortex · doi:10.1016/j.cortex.2013.04.002 · Cited by 56
The ethics of elective psychopharmacology
Mohamed, A. D., & Sahakian, B. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100037x · Cited by 56
Galloway, E. M., Woo, N. H., & Lu, B. (2008) · Progress in brain research · doi:10.1016/s0079-6123(07)00015-5 · Cited by 57
Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome
Gothelf, D., Hoeft, F., Hinard, C., Hallmayer, J. F., Stoecker, J. V. D., Antonarakis, S. E., Morris, M. A., & Reiss, A. L. (2007) · Human Brain Mapping · doi:10.1002/hbm.20405 · Cited by 55
Association between the Casein Kinase 1 Epsilon Gene Region and Subjective Response to D-Amphetamine
Veenstra-VanderWeele, J. M., Qaadir, A., Palmer, A. A., Cook, E. H., & de Wit, H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300936 · Cited by 55
The COMT Val158Met polymorphism modulates working memory performance under acute stress
Buckert, M., Kudielka, B. M., Reuter, M., & Fiebach, C. J. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.014 · Cited by 60
Karlsgodt, K. H., Bachman, P., Winkler, A. M., Bearden, C. E., & Glahn, D. C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.016 · Cited by 58
Neural response to working memory load varies by dopamine transporter genotype in children
Stollstorff, M., Foss‐Feig, J. H., Cook, E. H., Stein, M. A., Gaillard, W. D., & Vaidya, C. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.104 · Cited by 58
Kelly, C. A. M., Hester, R., Foxe, J. J., Shpaner, M., & Garavan, H. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.008 · Cited by 54
Association Between Hypnotizability and the Catechol-O-Methyltransferase (COMT) Polymorphism
Szekely, A., Kovacs-Nagy, R., Bányai, É. I., Gősi-Greguss, A. C., Varga, K., Halmai, Z., Ronai, Z., & Sasvari-Szekely, M. (2010) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207141003760827 · Cited by 53
A Thalamocorticostriatal Dopamine Network for Psychostimulant-Enhanced Human Cognitive Flexibility
Samanez-Larkin, G. R., Buckholtz, J. W., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Arrington, C. M., Baldwin, R. M., Smith, C. E., Treadway, M. T., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.032 · Cited by 58
Müller, U., Suckling, J., Zelaya, F. O., Honey, G. D., Faessel, H. M., Williams, S., Routledge, C. A., Brown, J. R., Robbins, T. W., & Bullmore, E. T. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2264-9 · Cited by 52
Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review
Fond, G. B., Micoulaud‐Franchi, J., Brunel, L., Macgregor, A., Miot, S., Lopez, R., Richieri, R. M., Abbar, M., Lançon, C., & Repantis, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.006 · Cited by 52
Hamidovic, A., Dlugos, A. M., Palmer, A. A., & de Wit, H. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a1f3c · Cited by 52
COMT as a Drug Target for Cognitive Functions and Dysfunctions
Scheggia, D., Sannino, S., Scattoni, M. L., & Papaleo, F. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800672481 · Cited by 51
Roffman, J. L., Weiss, A. P., GOFF, D. C., Rauch, S. L., & Weinberger, D. R. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600642945 · Cited by 53
Self-citationLipska, B. K., Mitkus, S. N., Caruso, M., Hyde, T. M., Chen, J., Vakkalanka, R., Straub, R. E., Weinberger, D. R., & Kleinman, J. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl222 · Cited by 54
Self-citationSecher, A., Bukh, J. D., Bock, C., Koefoed, P., Rasmussen, H. B., Werge, T. M., Kessing, L. V., & Mellerup, E. T. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832d6be2 · Cited by 51
Soeiro‐de‐Souza, M. G., Machado‐Vieira, R., Bio, D. S., do Prado, C. M., & Moreno, R. A. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01030.x · Cited by 51
Peerbooms, O., Rutten, B. P. F., Collip, D., Lardinois, M., Lataster, T., Thewissen, V., Rad, S. M., Drukker, M., Kenis, G., van Os, J., et al. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01806.x · Cited by 51
Favaro, A., Clementi, M., Manara, R., Bosello, R., Forzan, M., Bruson, A., Tenconi, E., Degortes, D., Titton, F., Salle, F. D., et al. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120068 · Cited by 52
Greenwood, P. M., Lin, M., Sundararajan, R., Fryxell, K. J., & Parasuraman, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807891106 · Cited by 51
Prefrontal dopamine and the dynamic control of human long-term memory
Wimber, M., Schott, B. H., Wendler, F., Seidenbecher, C. I., Behnisch, G., Macharadze, T., Bäuml, K.-H. T., & Richardson‐Klavehn, A. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.15 · Cited by 51
Wardle, M. C., de Wit, H., Penton‐Voak, I. S., Lewis, G., & Munafo, M. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.24 · Cited by 49
Franke, B. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1335 · Cited by 53
D’Souza, U. M., & Craig, I. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00904-7 · Cited by 50
Differential effects of COMT on gait and executive control in aging
Holtzer, R., Ozelius, L. J., Xue, X., Wang, T. C., Lipton, R. B., & Verghese, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.011 · Cited by 52
Raznahan, A., GREENSTEIN, D. K., Lee, Y., Long, R., CLASEN, L. S., Gochman, P., Addington, A. M., Giedd, J. N., Rapoport, J. L., & Gogtay, N. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.032 · Cited by 50
Recent advances in treating cognitive impairment in schizophrenia
Galletly, C. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1302-9 · Cited by 49
Hohoff, C., McDonald, J. M., Baune, B. T., Cook, E. H., Deckert, J., & de Wit, H. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30228 · Cited by 50
What can research on schizophrenia tell us about the cognitive neuroscience of working memory?
Barch, D. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.013 · Cited by 57
OPRM1 gene variants modulate amphetamine-induced euphoria in humans
Dlugos, A. M., Hamidovic, A., Hodgkinson, C. A., Shen, P., Goldman, D. A., Palmer, A. A., & de Wit, H. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00655.x · Cited by 49
Li, Z., Mulligan, M. K., Wang, X., Miles, M. F., Lu, L., & Williams, R. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012181 · Cited by 48
Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity
Wang, M., Ma, Y., Yuan, W., Su, K., & Li, M. D. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9651-3 · Cited by 53
Gower, A., & Tiberi, M. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00018 · Cited by 51
Hansson, A. C., Gründer, G., Hirth, N., Noori, H. R., Spanagel, R., & Sommer, W. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.010 · Cited by 55
Gibbs, S. E. B., & D’Esposito, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.055 · Cited by 49
The Downsides of Cognitive Enhancement
Colzato, L. S., Hommel, B., & Beste, C. (2020) · The Neuroscientist · doi:10.1177/1073858420945971 · Cited by 45
COMT and ANKK1-Taq-Ia Genetic Polymorphisms Influence Visual Working Memory
Berryhill, M. E., Wiener, M., Stephens, J. A., Lohoff, F. W., & Coslett, H. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055862 · Cited by 57
Schlagenhauf, F., Dinges, M., Beck, A., Wüstenberg, T., Friedel, E., Dembler, T., Sarkar, R., Wrase, J., Gallinat, J., Juckel, G., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.01.022 · Cited by 49
Differential effects of white noise in cognitive and perceptual tasks
Herweg, N. A., & Bunzeck, N. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01639 · Cited by 51
Dopaminergic Neuromodulation of Semantic Processing: A 4-T fMRI Study with Levodopa
Copland, D. A., McMahon, K. L., Silburn, P. A., & de Zubicaray, G. I. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp017 · Cited by 47
Opgen‐Rhein, C., Neuhaus, A. H., Urbanek, C., Hahn, E. W., Sander, T., & Dettling, M. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm155 · Cited by 47
Lapish, C. C., Balaguer-Ballester, E., Seamans, J. K., Phillips, A. G., & Durstewitz, D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2421-14.2015 · Cited by 45
Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease
Fallon, S. J., Smulders, K., Esselink, R. A. J., van de Warrenburg, B. P. C., Bloem, B. R., & Cools, R. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.07.031 · Cited by 50
Kimoto, S., Muraki, K., Toritsuka, M., Mugikura, S.-I., Kajiwara, K., Kishimoto, T., Illingworth, E. A., & Tanigaki, K. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.70 · Cited by 48
Huuhka, K., Anttila, S. A. K., Huuhka, M., Hietala, J. A., Huhtala, H., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.015 · Cited by 46
Gosso, M. F., de Geus, E. J. C., Polderman, T. J. C., Boomsma, D. I., Heutink, P., & Posthuma, D. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.57 · Cited by 46
Green, A. E., Kraemer, D. J. M., DeYoung, C. G., Fossella, J., & Gray, J. R. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs035 · Cited by 48
Memory Deficits in Aging and Neurological Diseases
Khan, Z. U., Martín‐Montañez, E., Navarro‐Lobato, I., & Muly, E. C. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00001-5 · Cited by 48
5.4 Dopaminergic Modulation of Flexible Cognitive Control in Humans
Cools, R., & D’Esposito, M. (2009) · Dopamine Handbook · doi:10.1093/acprof:oso/9780195373035.003.0017 · Cited by 46
Dopamine Modulation of the Prefrontal Cortex and Cognitive Function
Seamans, J. K., & Robbins, T. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-333-6_14 · Cited by 47
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics
Diaz-Asper, C. M., Weinberger, D. R., & Goldberg, T. E. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.010 · Cited by 45
Self-citationFunctional neural anatomy of talent
Kalbfleisch, M. L. (2004) · The Anatomical Record Part B The New Anatomist · doi:10.1002/ar.b.20010 · Cited by 47
Imaging genetic influences in human brain function
Mattay, V. S., & Goldberg, T. E. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.014 · Cited by 47
Self-citationfMRI evidence for functional epistasis between COMT and RGS4
Buckholtz, J. W., Sust, S., Tan, H. Y., Mattay, V. S., Straub, R. E., Meyer‐Lindenberg, A., Weinberger, D. R., & Callicott, J. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002008 · Cited by 44
Self-citationNobile, M., Rusconi, M., Bellina, M., Marino, C., Giorda, R., Carlet, O., Vanzin, L., Molteni, M., & Battaglia, M. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0080-1 · Cited by 46
Schellekens, A., Franke, B., Ellenbroek, B. A., Cools, A. R., de Jong, C. A. J., Buitelaar, J. K., & Verkes, R. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00438.x · Cited by 44
Functional Genomics and Schizophrenia: Endophenotypes and Mutant Models
Waddington, J. L., Corvin, A. P., Donohoe, G. J., O’Tuathaigh, C. M. P., Mitchell, K. J., & Gill, M. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.011 · Cited by 45
Biomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 42
Brain activity, low self-control, and delinquency: An fMRI study of at-risk adolescents
Meldrum, R. C., Trucco, E. M., Cope, L. M., Zucker, R. A., & Heitzeg, M. M. (2017) · Journal of Criminal Justice · doi:10.1016/j.jcrimjus.2017.07.007 · Cited by 43
Evaluating endophenotypes for bipolar disorder
Guglielmo, R., Miskowiak, K. W., & Hasler, G. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-021-00220-w · Cited by 46
Cheon, K.-A. A., Jun, J.-Y., & Cho, D.-Y. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328306a977 · Cited by 45
Kline, R. L., Zhang, S., Farr, O. M., Hu, S., Záborszky, L., Samanez-Larkin, G. R., & Li, C. R. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00149 · Cited by 43
Dahl, R. E., & Hariri, A. R. (2005) · Journal of Research on Adolescence · doi:10.1111/j.1532-7795.2005.00102.x · Cited by 45
Self-citationHernaus, D., Collip, D., Lataster, J., Ceccarini, J., Kenis, G., Booij, L., Pruessner, J. C., Laere, K. V., van Winkel, R., van Os, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065662 · Cited by 41
Flanagin, B. A., Cook, E. H., & de Wit, H. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30327 · Cited by 41
McCracken, J., Badashova, K., Posey, D., Aman, M., Scahill, L., Tierney, E., Arnold, L., Vitiello, B., Whelan, F., Chuang, S. Z., et al. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.23 · Cited by 44
Neurorepair versus Neuroprotection in Stroke
Hurtado, O., Pradillo, J. M., Alonso‐Escolano, D., Lorenzo, P., Sobrino, T., Castillo, J., Lizasoaín, I., & Moro, M. Á. (2006) · Cerebrovascular Diseases · doi:10.1159/000091704 · Cited by 41
First- and second-generation antipsychotic medication and cognitive processing in schizophrenia
Weickert, T. W., & Goldberg, T. E. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0085-5 · Cited by 41
Self-citationCatechol O-Methyltransferase Polymorphism and Eye Tracking in Schizophrenia: A Preliminary Report
Thaker, G. K., Wonodi, I., Avila, M. T., Hong, L. E., & Stine, O. C. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.12.2320 · Cited by 42
Eckart, C., Fuentemilla, L., Bauch, E. M., & Bunzeck, N. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.03.011 · Cited by 43
Takizawa, R., Tochigi, M., Kawakubo, Y., Marumo, K., Sasaki, T., Fukuda, M., & Kasai, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005495 · Cited by 41
Norepinephrine Transporter Gene Variation Modulates Acute Response to d-Amphetamine
Dlugos, A. M., Freitag, C. M., Hohoff, C., McDonald, J. M., Cook, E. H., Deckert, J., & de Wit, H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.031 · Cited by 40
Ullsperger, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.009 · Cited by 41
Noradrenergic blockade and numeric working memory in humans
Müller, U., Mottweiler, E., & Bublak, P. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048888 · Cited by 40
Personality and the acute subjective effects of d -amphetamine in humans
Kirkpatrick, M. G., Johanson, C.-E., & de Wit, H. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112472564 · Cited by 39
Metadata
- Authors
- Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-04-25
- Volume
- 100
- Issue
- 10
- Pages
- 6186-6191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC156347
- OpenAlex
- W2123636362
- Cited by
- 893
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 30 · 2016: 34 · 2015: 51 · 2014: 50 · 2013: 66 · 2012: 61
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, amphetamine, prefrontal cortex, working memory, dopamine signaling, pharmacogenomics, individual differences, monoaminergic systems
- MeSH terms
- Brain, Catechol O-Methyltransferase, Dextroamphetamine, DNA, Genotype, Humans, Magnetic Resonance Imaging, Methionine, Organ Specificity, Valine, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
